Jean-Henri Bourhis Selected Research

Jean-Henri Bourhis Research Topics

17	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 08/2003
10	Leukemia 01/2020 - 06/2007
8	Neoplasms (Cancer) 01/2019 - 08/2007
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019 - 03/2015
3	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 03/2004
3	Pathologic Complete Response 11/2018 - 05/2008
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2018 - 07/2004
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2016 - 07/2006
3	Philadelphia Chromosome 06/2015 - 10/2002
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2015 - 10/2002
3	Multiple Myeloma 01/2013 - 11/2006
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2020 - 07/2003
2	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2018 - 01/2018
2	Hodgkin Disease (Hodgkin's Disease) 11/2018 - 09/2013
2	Lymphoma (Lymphomas) 01/2018 - 05/2007
1	Infections 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Hematologic Diseases (Blood Diseases) 01/2019
1	Yellow Fever 01/2018
1	Microsporidiosis 01/2017
1	Neutropenia 07/2015
1	Progressive Multifocal Leukoencephalopathy 09/2014
1	Lymphopenia (Lymphocytopenia) 09/2014
1	Blast Crisis (Blast Phase) 11/2013
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 05/2013
1	Plasmacytoma 01/2013
1	Myeloid Leukemia (Leukemia, Myelocytic) 07/2006
1	Multi-centric Castleman's Disease 12/2003
1	Amyloidosis 12/2003
1	Bronchiolitis Obliterans Syndrome 11/2002
1	Residual Neoplasm 10/2002

3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2021 - 01/2018
3	Tyrosine Kinase InhibitorsIBA 06/2016 - 11/2013
2	Busulfan (Busulfex)FDA Link 11/2018 - 11/2016
2	Clofarabine (Clolar)FDA Link 11/2018 - 11/2016
2	Daunorubicin (Cerubidine)FDA LinkGeneric 12/2015 - 02/2010
2	AnthracyclinesIBA 12/2015 - 02/2010
2	Cytarabine (Cytosar-U)FDA LinkGeneric 08/2011 - 02/2010
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021
1	Core Binding Factors (Core-Binding Factor)IBA 01/2020
1	Calcineurin InhibitorsIBA 12/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2018
1	Carmustine (FIVB)FDA Link 11/2018
1	Melphalan (Alkeran)FDA LinkGeneric 11/2018
1	Etoposide (VP 16)FDA LinkGeneric 11/2018
1	AntibodiesIBA 01/2018
1	fumagillinIBA 01/2017
1	fludarabineIBA 11/2016
1	Pharmaceutical PreparationsIBA 12/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2015
1	Interleukin-7 (Interleukin 7)IBA 09/2014
1	Azacitidine (5 Azacytidine)FDA Link 11/2013
1	IPH-2101IBA 11/2012
1	KIR ReceptorsIBA 11/2012
1	trans-sodium crocetinate (crocetin)IBA 08/2011
1	Interleukin-2 (IL2)IBA 02/2010
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 02/2010
1	Rituximab (Mabthera)FDA Link 05/2007
1	Thalidomide (Thalomid)FDA Link 11/2006
1	Oncogene Proteins (Oncogene Protein)IBA 07/2006
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2006
1	galactomannanIBA 03/2004
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 03/2004
1	AntigensIBA 03/2004
1	Monoclonal AntibodiesIBA 12/2003
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2002

19	Therapeutics 01/2020 - 10/2002
18	Stem Cell Transplantation 01/2021 - 10/2002
8	Drug Therapy (Chemotherapy) 12/2020 - 12/2003
7	Transplantation 01/2021 - 11/2002
7	Hematopoietic Stem Cell Transplantation 01/2021 - 05/2008
5	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2020 - 09/2013
4	Cell Transplantation 01/2021 - 01/2019
2	Autologous Transplantation 01/2020 - 08/2007
2	Homologous Transplantation 01/2018 - 04/2012
2	Induction Chemotherapy 02/2010 - 06/2007
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 03/2015
1	Remission Induction 02/2010